Orthofix Medical Inc.

Annual Trend FY 2016 FY 2017 FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025
Cash flows from operating activities:
Adjustments to reconcile net income to net cash provided by operating activities:
Net Income (Loss) Attributable to Parent $3.1m $6.2m $13.8m ($28.5m) $2.5m ($38.4m) ($19.7m) ($151.4m) ($126.0m) ($92.2m)
Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent $3.5m $7.3m $13.8m ($28.5m)
Depreciation, Depletion and Amortization $20.8m $20.1m $18.7m $24.7m $30.5m $29.6m $29.0m $53.1m $60.1m $77.3m
Depreciation $19.0m $18.3m $15.9m $17.7m $19.3m $20.2m $19.6m $34.2m $41.1m $47.3m
Amortization of Intangible Assets $1.8m $1.8m $2.7m $7.0m $11.2m $9.4m $9.4m $18.9m $19.0m $30.0m
Capitalized Computer Software, Amortization $6.4m
Deferred Income Tax Expense (Benefit) $10.5m $21.3m ($2.7m) $1.4m $10.8m $24.5m $314k $579k $1.9m $223k
Share-based Payment Arrangement, Noncash Expense $16.0m $12.6m $18.9m $21.5m $16.2m $15.4m $18.4m $35.7m $32.5m $28.7m
Payment, Tax Withholding, Share-based Payment Arrangement $2.4m $3.8m $3.4m $5.2m $2.5m $2.6m $1.7m $4.4m $5.3m $432k
Share-based Payment Arrangement, Expense $16.0m $12.6m $18.9m $21.5m $16.2m $15.4m $18.4m $35.7m $32.5m $28.7m
Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount ($4.7m)
Goodwill, Impairment Loss $11.8m
Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property ($2.0m) ($1.1m)
Income Tax Expense (Benefit) $15.5m $29.1m $9.1m $1.4m ($2.9m) $24.9m $2.0m $2.7m $2.1m $1.4m
Other Nonoperating Income (Expense) ($2.8m) ($4.0m) ($6.4m) ($8.1m) $8.4m ($3.3m) ($3.1m) ($938k) ($9.6m) $8.1m
Changes in operating assets and liabilities:
Additional Financial Items
Increase (Decrease) in Accounts Receivable ($392k) $6.6m $3.7m $11.0m ($13.3m) $7.0m $6.7m $10.4m $9.5m $1.6m
Increase (Decrease) in Inventories $5.3m $15.6m ($9.7m) $5.7m $873k ($619k) $18.1m $58.1m $5.5m $10.7m
Increase (Decrease) in Accounts Payable ($1.8m) $2.3m ($170k) $2.1m $2.5m $4.3m $2.3m $8.6m ($5.6m) $2.6m
Foreign Currency Transaction Gain (Loss), before Tax ($1.6m) $4.4m ($2.9m)
Gain (Loss) on Investments $1.8m $5.1m ($48k)
Gain (Loss) Related to Litigation Settlement ($14.4m) ($14.5m) ($15.8m) ($33.8m)
General and Administrative Expense $74.4m $74.4m $84.5m $85.6m $67.9m $69.4m $80.0m $144.7m
Goodwill $53.6m $53.6m $72.4m $71.2m $84.0m $71.3m $71.3m $194.9m $194.9m $194.9m
Inventory Write-down $400k
Operating Expenses $300.9m $300.0m $326.3m $378.1m
Provision for Loan, Lease, and Other Losses $2.0m $2.3m
Restructuring Costs $3.0m
Discontinued Operation, Income (Loss) from Discontinued Operation During Phase-out Period, Net of Tax ($441k) ($1.1m)
Net Cash Provided by (Used in) Operating Activities $44.7m $53.3m $49.9m $32.0m $74.3m $18.5m ($11.5m) ($45.8m) $25.8m $33.3m
Cash flows from investing activities:
Payments to Acquire Property, Plant, and Equipment $16.4m $14.7m $13.6m $19.0m $15.5m $17.8m $21.4m $60.3m $34.9m $34.6m
Payments to Acquire Businesses, Net of Cash Acquired $44.3m
Payments to Acquire Investments $500k
Payments for (Proceeds from) Other Investing Activities ($474k) $500k $100k ($28k)
Net Cash Provided by (Used in) Investing Activities ($21.9m) ($16.5m) ($61.0m) ($22.9m) ($52.3m) ($23.0m) ($24.5m) ($33.1m) ($27.6m) ($34.6m)
Cash flows from financing activities:
Proceeds from Issuance of Common Stock $19.7m $7.8m $7.1m $11.6m $7.6m $8.8m $4.3m $5.1m $6.3m $5.9m
Net Cash Provided by (Used in) Financing Activities ($46.1m) $3.5m $3.0m ($10.7m) $3.2m ($3.6m) ($78k) $65.3m $50.7m ($786k)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect ($739k) $1.2m ($9.0m) ($1.8m) $26.4m ($9.0m) ($37.1m) ($12.9m) $48.0m ($623k)
Supplemental disclosure of cash flow information:
Interest Paid, Excluding Capitalized Interest, Operating Activities $672k $811k $800k $800k $1.9m $1.5m $1.4m $5.8m $16.9m $17.3m
Income Taxes Paid, Net $1.6m